Brain Injury Clinical Trial
Official title:
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery,A Randomized Controlled Study
Verified date | April 2014 |
Source | Shaanxi Provincial People's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Food and Drug Administration |
Study type | Interventional |
The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life
quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD,
and POCD is also correlated with many other factors such as type of surgery, the duration of
anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in
geriatrics is important.
Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy
whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the
prolonged surgery.
The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive
function at prolonged surgery in geriatrics in geriatrics.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | August 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: 1. Written informed consent 2. Scheduled for elective abdominal surgery 3. Age=65 yrs 4. Weight is within the range of ±20% of standard weight [standard weight=Height(cm)-80)×70? for male and(Height(cm)-70)×60?] for female 5. American society of anesthesia classification I~III 6. Expected time of surgery is more than 4 hours - Exclusion Criteria: 1. Systolic blood pressure=180 mm Hg or <90 mm Hg,diastolic blood pressure=110 mm Hg or < 60 mm Hg; 2. Serious cardiac,liver,kidney,lung, endocrine disease or sepsis. 3. Allergy to trial drug or other contraindication; 4. Difficult airway occurred before,or difficult airway possibly occurred and difficult to extubation 5. History of mental illness and cerebral vascular disease 6. History of unstable angina or myocardial infarction 7. Education level<7 yrs 8. Factors existed that affect cognition assessment such as language, visual sense,auditory sense disorders. 9. Abuse of narcotic analgesia or suspected; 10. Neuromuscular diseases; 11. Mentally unstable or has a mental illness; 12. Pregnant or breast-feeding women; 13. Attended other trial past 30 days; - |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shaanxi Provincial People's Hospital | Chinese Medical Association |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in cognitive function at 7 days | Modified Newman scale to assess the cognitive function, including five tests. The quiet environment, enough daylight, no disturb is needed when the modified Newman scale is done. All the five tests are finished within 30 min. all the score of each test of all the patients assessed before the surgery is calculated, then get the standard variation, the score of each subject of each test is compared with the standard deviation, if one or more stand deviation decrease, then the cognitive function is considered as deterioration . When 2 or more of the tests is considered as deterioration, then the patients is diagnosed as Post Operation Cognitive Dysfunction (POCD). |
Baseline, the 7th day after the surgery | Yes |
Secondary | Brain injury assessment | 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery. The serum level of C-reaction protein(CRP),tumor necrosis factor(TNF-a)?interleukin-6(IL-6),interleukin-10(IL-10) is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA) |
From entering the operating room to 48 hours after the surgery | Yes |
Secondary | Inflammatory responsive assessment | 2 ml blood sample is collected at 8 time points including before surgery,the right moment,2 hr and 4 hr after the induction, the right moment,12,24 and 48 hours after the surgery. The concentration of protein S100B(S100B)and neuron specific enolase (NSE)in serum is tested using immunohistochemical double antibody sandwich enzyme-linked immunosorbent assay (ELISA). |
From entering the operating room to 48 hours after the surgery | Yes |
Secondary | Heart rate | Heart rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Depth of anesthesia | Bispectral index(BIS) monitor are performed every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | No |
Secondary | Recovery of anesthesia | Time of anesthetic ceased,time of call to open eyes,time to extubation, time to leave the PACU are recorded. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Central venous pressure(CVP) | Central venous pressure(CVP) are monitored every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Blood pressure | systolic blood pressure, Diastolic blood pressure are monitored every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Respiration rate | Respiration rate are monitored every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Pulse blood oxygen saturation | Pulse blood oxygen saturation are monitored every 15 min from the induction of anesthesia to the right moment of extubation. | From the induction of anesthesia to the right moment of extubation, up to 1 day. | Yes |
Secondary | Number of Participants with Serious and Non-Serious Adverse Events | Up to 7 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02710123 -
Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion
|
N/A | |
Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
Completed |
NCT02262286 -
MIND (Management of Traumatic Brain Injury Diagnosis)
|
N/A | |
Completed |
NCT01461902 -
Vasospasm in Pediatric Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT01198964 -
Optimization of Human Cortical Stimulation
|
||
Active, not recruiting |
NCT01207050 -
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
|
Phase 4 | |
Completed |
NCT00875329 -
Traumatic Brain Injury (TBI) Screening Instruments
|
N/A | |
Completed |
NCT01201863 -
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
|
Phase 4 | |
Completed |
NCT01059890 -
Cerebral Antibiotics Distribution After Acute Brain Injury
|
Phase 1 | |
Completed |
NCT01035606 -
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
|
N/A | |
Completed |
NCT00596765 -
Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury
|
N/A | |
Completed |
NCT00571623 -
Automated Chest Physiotherapy to Improve Outcomes in Neuro
|
N/A | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 | |
Recruiting |
NCT05105763 -
Biofeedback Gait Retraining for Stiff Knee Gait Correction
|
N/A | |
Recruiting |
NCT02495558 -
Cough Assessment in Patients With Severe Acquired Brain Injury
|
N/A | |
Completed |
NCT02100592 -
Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study
|
Phase 1/Phase 2 | |
Completed |
NCT00797680 -
Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest
|
Phase 2 | |
Completed |
NCT00018499 -
Genotype Influence on Recovery After Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT02567201 -
Electrophysiological Evaluation of Voluntary Attention
|
N/A | |
Withdrawn |
NCT05581927 -
Whole-Body Hypothermia for Neonates With Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A |